Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

06.01.25 12:00 Uhr

Werte in diesem Artikel
Aktien

74,00 EUR -2,00 EUR -2,63%

BOSTON, Jan. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time.

The public may access Mr. Simon's presentation live via audio webcast at:

https://jpmorgan.metameetings.net/events/healthcare25/sessions/58190-haemonetics-corporation/webcast?gpu_only=true&kiosk=true 

The live webcast can also be accessed under the Events & Presentations section of Haemonetics' Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Haemonetics' Investor Relations website beginning approximately one hour after completion of the live event.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:                                              


Olga Guyette, Vice President-Investor Relations & Treasury     

David Trenk, Manager-Investor Relations

(781) 356-9763                                                                         

(203) 733-4987

olga.guyette@haemonetics.com                                           

david.trenk@haemonetics.com                                                                                



Media Contact:                                                           


Josh Gitelson, Sr. Director-Global Communications       


(781) 356-9776


josh.gitelson@haemonetics.com 


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-43rd-annual-jp-morgan-healthcare-conference-302342258.html

SOURCE Haemonetics Corporation

Ausgewählte Hebelprodukte auf Haemonetics

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Haemonetics

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Haemonetics Corp.

Wer­bung

Analysen zu Haemonetics Corp.

DatumRatingAnalyst
07.08.2019Haemonetics OutperformBarrington Research
08.05.2019Haemonetics OutperformBarrington Research
09.08.2018Haemonetics OutperformBarrington Research
07.02.2018Haemonetics OutperformBarrington Research
08.11.2017Haemonetics OutperformBarrington Research
DatumRatingAnalyst
07.08.2019Haemonetics OutperformBarrington Research
08.05.2019Haemonetics OutperformBarrington Research
09.08.2018Haemonetics OutperformBarrington Research
07.02.2018Haemonetics OutperformBarrington Research
08.11.2017Haemonetics OutperformBarrington Research
DatumRatingAnalyst
07.02.2017Haemonetics Mkt PerformBarrington Research
07.11.2016Haemonetics HoldThe Benchmark Company
11.05.2016Haemonetics HoldThe Benchmark Company
05.11.2015Haemonetics HoldThe Benchmark Company
16.08.2006Update Haemonetics Corp.: HoldStanford Research
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Haemonetics Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"